Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia.
about
Molecular basis of β thalassemia and potential therapeutic targets.Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemiaPathophysiology and treatment of patients with beta-thalassemia - an update.Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control
P2860
Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Selective silencing of α-globi ...... or treatment of β-thalassemia.
@en
Selective silencing of α-globi ...... or treatment of β-thalassemia.
@nl
type
label
Selective silencing of α-globi ...... or treatment of β-thalassemia.
@en
Selective silencing of α-globi ...... or treatment of β-thalassemia.
@nl
prefLabel
Selective silencing of α-globi ...... or treatment of β-thalassemia.
@en
Selective silencing of α-globi ...... or treatment of β-thalassemia.
@nl
P2093
P2860
P1433
P1476
Selective silencing of α-globi ...... or treatment of β-thalassemia.
@en
P2093
Christopher A Fisher
Jackie A Sloane-Stanley
Richard J Gibbons
Stephen Taylor
Udo Oppermann
P2860
P304
P356
10.3324/HAEMATOL.2016.155655
P577
2016-11-03T00:00:00Z